Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-doublet Chemotherapy for Non-small Cell Lung Cancer Harboring EGFR Mutation.
Shintaro Kanda; Seiji Niho; Takayasu Kurata; Shogo Nomura; Yosuke Kawashima; Eiji Iwama; Toshihide Yokoyama; Yasutaka Watanabe; Hiroshi Tanaka; Yutaka Fujiwara; Yoshitaka Zenke; Koichi Azuma; Hirokazu Taniguchi; Ryo Toyozawa; Yukio Hosomi; Haruyasu Murakami; Satoshi Hara; Akihiro Bessho; Nobuyuki Yamamoto; Yuichiro Ohe
Clinical cancer research : an official journal of the American Association for Cancer Research, 31 Mar. 2025

Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529).
Takaaki Tokito; Kazuhiko Yamada; Hidenobu Ishii; Yuichi Takiguchi; Go Saito; Koichi Minato; Hisao Imai; Hiroshi Tanaka; Satoru Miura; Kageaki Watanabe; Yoshifusa Koreeda; Akira Ono; Naoki Furuya; Toshihiro Misumi; Kazushige Hayakawa; Etsuyo Ogo; Hiroaki Okamoto
Radiation oncology (London, England), 04 Jan. 2025

Novel endoscopic approach for safe and effective resection of duodenal neuroendocrine tumor.
Shinpei Minami; Shuhei Fukunaga; Michita Mukasa; Daiki Ohzono; Hiroshi Tanaka; Tomoyuki Nakane; Hidetoshi Takedatsu
Endoscopy, Dec. 2024

Survival and Endoscopic/Clinical Features of Patients with Colorectal Cancer Resected by Cold Snare Polypectomy: The Importance of Chronic Kidney Disease.
Tsutomu Nagata; Miwa Sakai; Michita Mukasa; Hiroshi Tanaka; Shinpei Minami; Tomonori Cho; Tomoyuki Nakane; Akihiro Ohuchi; Shuhei Fukunaga; Jun Akiba; Yoshinobu Okabe; Takumi Kawaguchi
The Kurume medical journal, 27 Sep. 2024

Corrigendum to "A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKI and platinum-based chemotherapy" [Lung Cancer 177 (2023) 44-50].
Masayuki Takeda; Mototsugu Shimokawa; Atsushi Nakamura; Kaname Nosaki; Yasutaka Watanabe; Terufumi Kato; Daisuke Hayakawa; Hiroshi Tanaka; Toshiaki Takahashi; Masahide Oki; Motoko Tachihara; Daichi Fujimoto; Hidetoshi Hayashi; Kakuhiro Yamaguchi; Shoichiro Yamamoto; Eiji Iwama; Koichi Azuma; Kazuo Hasegawa; Nobuyuki Yamamoto; Kazuhiko Nakagawa
Lung cancer (Amsterdam, Netherlands), Jul. 2024

Impact of metabolic dysfunction-associated fatty liver disease on the incidence of Helicobacter pylori-negative gastric cancer.
Tomoyuki Nakane; Shuhei Fukunaga; Dan Nakano; Tsubasa Tsutsumi; Hiroshi Tanaka; Tomonori Chou; Shinpei Minami; Akihiro Ohuchi; Tsutomu Nagata; Kota Takaki; Hiroshi Takaki; Ichiro Miyajima; Ryuichi Nouno; Shinobu Yoshinaga; Michita Mukasa; Yoshinobu Okabe; Takumi Kawaguchi
Hepatology research : the official journal of the Japan Society of Hepatology, Jun. 2024

Impact of non-obese metabolic dysfunction-associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter study.
Shuhei Fukunaga; Michita Mukasa; Tomoyuki Nakane; Dan Nakano; Tsubasa Tsutsumi; Tomonori Chou; Hiroshi Tanaka; Daiki Hayashi; Shinpei Minami; Akihiro Ohuchi; Tsutomu Nagata; Kota Takaki; Hiroshi Takaki; Ichiro Miyajima; Ryuichi Nouno; Toshihiro Araki; Taku Morita; Takuji Torimura; Yoshinobu Okabe; Takumi Kawaguchi
Hepatology research : the official journal of the Japan Society of Hepatology, Feb. 2024

Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407.
Shunichi Sugawara; Kentaro Tanaka; Fumio Imamura; Nobuyuki Yamamoto; Makoto Nishio; Kyoichi Okishio; Tomonori Hirashima; Hiroshi Tanaka; Tatsuro Fukuhara; Yasuharu Nakahara; Takayasu Kurata; Nobuyuki Katakami; Morihito Okada; Hidehito Horinouchi; Hibiki Udagawa; Kazuo Kasahara; Miyako Satouchi; Hideo Saka; Takaaki Tokito; Yukio Hosomi; Keisuke Aoe; Kazuma Kishi; Kadoaki Ohashi; Takuma Yokoyama; Noriaki Adachi; Kazuo Noguchi; Paul Schwarzenberger; Terufumi Kato
Cancer science, Aug. 2023

A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKIs and platinum-based chemotherapy.
Masayuki Takeda; Mototsugu Shimokawa; Atsushi Nakamura; Kaname Nosaki; Yasutaka Watanabe; Terufumi Kato; Daisuke Hayakawa; Hiroshi Tanaka; Toshiaki Takahashi; Masahide Oki; Motoko Tachihara; Daichi Fujimoto; Hidetoshi Hayashi; Kakuhiro Yamaguchi; Shoichiro Yamamoto; Eiji Iwama; Koichi Azuma; Kazuo Hasegawa; Nobuyuki Yamamoto; Kazuhiko Nakagawa
Lung cancer (Amsterdam, Netherlands), Mar. 2023

Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.
Hiroshi Sakai; Masahiro Morise; Terufumi Kato; Shingo Matsumoto; Tomohiro Sakamoto; Toru Kumagai; Takaaki Tokito; Shinji Atagi; Toshiyuki Kozuki; Hiroshi Tanaka; Kenichi Chikamori; Naofumi Shinagawa; Hiroaki Takeoka; Rolf Bruns; Josef Straub; Karl Maria Schumacher; Paul K Paik
Japanese journal of clinical oncology, 01 Aug. 2021

A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L).
Masayuki Takeda; Mototsugu Shimokawa; Atsushi Nakamura; Kaname Nosaki; Yasutaka Watanabe; Terufumi Kato; Daisuke Hayakawa; Hiroshi Tanaka; Toshiaki Takahashi; Yoshihito Kogure; Motoko Tachihara; Daichi Fujimoto; Kakuhiro Yamaguchi; Naohiko Hamaguchi; Isamu Okamoto; Koichi Azuma; Kazuo Hasegawa; Nobuyuki Yamamoto; Kazuhiko Nakagawa
Clinical lung cancer, Jul. 2021

Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 Trial.
Shingo Miyamoto; Koichi Azuma; Hidenobu Ishii; Akihiro Bessho; Shinobu Hosokawa; Nobuaki Fukamatsu; Hideo Kunitoh; Mari Ishii; Hiroshi Tanaka; Hiromi Aono; Yoshiro Nakahara; Kei Kusaka; Yukio Hosomi; Norihiro Kikuchi; Yoshiaki Mori; Hidetoshi Itani; Akinobu Hamada; Kazuhiko Yamada; Hiroaki Okamoto
JAMA oncology, 01 Jul. 2020

KEYNOTE-025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1-positive advanced non-small-cell lung cancer.
Makoto Nishio; Toshiaki Takahashi; Hiroshige Yoshioka; Kazuhiko Nakagawa; Tatsuro Fukuhara; Kazuhiko Yamada; Masao Ichiki; Hiroshi Tanaka; Takashi Seto; Hiroshi Sakai; Kazuo Kasahara; Miyako Satouchi; Shi Rong Han; Kazuo Noguchi; Takashi Shimamoto; Terufumi Kato
Cancer science, Mar. 2019

Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Motesanib (AMG-706) in Combination With Paclitaxel and Carboplatin in East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Kaoru Kubota; Hiroshige Yoshioka; Fumihiro Oshita; Toyoaki Hida; Kiyotaka Yoh; Hidetoshi Hayashi; Terufumi Kato; Hiroyasu Kaneda; Kazuhiko Yamada; Hiroshi Tanaka; Yukito Ichinose; Keunchil Park; Eun Kyung Cho; Kyung-Hee Lee; Chih-Bin Lin; James Chih-Hsin Yang; Kaori Hara; Takayuki Asato; Kazuhiko Nakagawa
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 10 Nov. 2017

Detection of the T790M mutation of EGFR in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study).
Takayuki Takahama; Kazuko Sakai; Masayuki Takeda; Koichi Azuma; Toyoaki Hida; Masataka Hirabayashi; Tetsuya Oguri; Hiroshi Tanaka; Noriyuki Ebi; Toshiyuki Sawa; Akihiro Bessho; Motoko Tachihara; Hiroaki Akamatsu; Shuji Bandoh; Daisuke Himeji; Tatsuo Ohira; Mototsugu Shimokawa; Yoichi Nakanishi; Kazuhiko Nakagawa; Kazuto Nishio
Oncotarget, 06 Sep. 2016

Can Early Aggressive Administration of Fresh Frozen Plasma Improve Outcomes in Patients with Severe Blunt Trauma?--A Report by the Japanese Association for the Surgery of Trauma.
Akiyoshi Hagiwara; Shigeki Kushimoto; Hiroshi Kato; Junichi Sasaki; Hiroshi Ogura; Tetsuya Matsuoka; Toshifumi Uejima; Mineji Hayakawa; Munekazu Takeda; Naoyuki Kaneko; Daizoh Saitoh; Yasuhiro Otomo; Hiroyuki Yokota; Teruo Sakamoto; Hiroshi Tanaka; Atsushi Shiraishi; Naoto Morimura; Hiroyasu Ishikura
Shock (Augusta, Ga.), May 2016

The impact of preoperative identification of the Adamkiewicz artery on descending and thoracoabdominal aortic repair.
Hiroshi Tanaka; Hitoshi Ogino; Kenji Minatoya; Yoshiro Matsui; Tetsuya Higami; Hitoshi Okabayashi; Yoshikatsu Saiki; Shigeyuki Aomi; Norihiko Shiiya; Yoshiki Sawa; Yutaka Okita; Taijiro Sueda; Hidetoshi Akashi; Yukio Kuniyoshi; Takahiro Katsumata
The Journal of thoracic and cardiovascular surgery, Jan. 2016

当院における大腸病変でのCold snare polypectomy(CSP)の現状と課題
田中寛士; 中根智幸; 永田務; 大内彬弘; 向笠道太; 福永秀平; 南真平; 長知徳; 林大樹; 秋葉純; 竹田津英稔; 岡部義信; 鶴田修; 川口巧
Gastroenterological Endoscopy (Web), 2023

H.pylori既感染胃に発生した純粋胃型形質癌の1例
林大樹; 田中寛士; 力武祐一郎; 南真平; 長知徳; 中根智幸; 永田務; 大内彬弘; 向笠道太; 光山慶一; 鳥村拓司
日本消化器病学会九州支部例会・日本消化器内視鏡学会九州支部例会プログラム・抄録集, 2022

当院における潰瘍性大腸炎に対するフィルゴチニブの治療成績
鶴田耕三; 鶴田耕三; 田中寛士; 田中寛士; 森田俊; 森田俊; 吉岡慎一郎; 吉岡慎一郎; 竹田津英稔; 竹田津英稔; 川口巧
日本消化器病学会九州支部例会・日本消化器内視鏡学会九州支部例会プログラム・抄録集, 2022

大腸悪性狭窄に対して留置した大腸ステントによって腸管穿孔をきたしかけた一例
田中寛士; 中尾昂史; 白地美紀; 梶原雅彦; 小野典之; 鳥村拓司
日本消化器病学会九州支部例会・日本消化器内視鏡学会九州支部例会プログラム・抄録集, 2020

当院で施行した大腸ステント留置の検討
田中寛士; 石井海人; 山口翔太郎; 南真平; 渡邉裕次郎; 草場喜雄; 渡辺靖友; 白地美紀; 梶原雅彦; 小野典之; 鳥村拓司
日本消化器病学会九州支部例会・日本消化器内視鏡学会九州支部例会プログラム・抄録集, 2020

腸重積症を契機に診断された小腸神経鞘腫の症例
南真平; 田中寛士; 相野一; 白地美紀; 梶原雅彦; 光山慶一; 鶴田修; 鳥村拓司
日本消化器病学会九州支部例会・日本消化器内視鏡学会九州支部例会プログラム・抄録集, 2019

診断に多くの鑑別を要し肝生検が有用であった自己免疫性肝炎の一例
中尾昂史; 田中寛士; 田中寛士; 南真平; 南真平; 白地美紀; 白地美紀; 梶原雅彦; 梶原雅彦; 小野典之; 鳥村拓司
日本消化器病学会九州支部例会・日本消化器内視鏡学会九州支部例会プログラム・抄録集, 2019

止血後に急速増大を来した食道胃接合部癌の症例
田中寛士; 南真平; 白地美紀; 梶原雅彦; 小野典之; 鶴田修; 鳥村拓司
日本消化器病学会九州支部例会・日本消化器内視鏡学会九州支部例会プログラム・抄録集, 2018

内科的治療が奏効した小腸静脈瘤破裂の2例
江森啓悟; 井上博人; 田中寛士; 久永宏; 国武泰史; 於保和彦; 豊永純; 鶴田修; 鳥村拓司
Gastroenterological Endoscopy (Web), 2017